Neural Therapeutics Inc.

CSE:NURL Canada Healthcare — Biotechnology

Neural Therapeutics Inc., an ethnobotanical drug discovery and development company, develops over-the-counter dietary supplements and psychedelic-based therapeutic drugs to treat mental illnesses in Canada. The company utilizes psychoactive…

neuraltherapeutics.ca

Click to toggle · Cmd+Click for exclusive

News 2026-05-19

Open PDF

Neural Portfolio Company Hanf.com Expands German Retail Footprint with New Muhldorf am Inn Store and Four Refurbished Locations

News release - English.pdf

Transactions 2026-05-01 M&A

Open PDF

Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE

News release - English.pdf

Transactions 2026-03-27 Financing

Open PDF

Neural Therapeutics Announces Amendment to SIO Agreement, Concurrent Financing Terms, Shareholder Meeting Date and RSU Grant

News release - English.pdf

Results 2026-03-26 Financials

Open PDF

Interim MD&A - English.pdf

Results 2026-03-26 Financials

Open PDF

Interim financial statements/report – English.pdf

Transactions 2026-02-19 M&A

Open PDF

Neural Therapeutics Announces CSE Application to Acquire Full Ownership of Hanf.com, Shareholder Meeting, SIO Agreement Amendment and Concurrent Financing

News release - English.pdf

Results 2026-02-10

Open PDF

Neural Portfolio Company Hanf.com Reports Strong Fiscal 2025 Results with 58% Revenue Growth and Positive Normalized Operating Income

News release - English.pdf

News 2026-01-27

Open PDF

Neural's Portfolio Company Hanf.com Announces Sales Start of Ritual Herbs Nicotine and Tobacco Free Products

News release - English.pdf

Results 2025-12-29 Financials

Open PDF

Interim MD&A - English.pdf